UnknownPhase 2NCT04470297

Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19

Studying Acute lung injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Associação Fundo de Incentivo à Pesquisa
Principal Investigator
Dalva Poyares, PhD
Associação Fundo de Incentivo a Pesquisa
Intervention
Ramelteon 8mg(drug)
Enrollment
100 enrolled
Eligibility
18-80 years · All sexes
Timeline
20202021

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04470297 on ClinicalTrials.gov

Other trials for Acute lung injury

Additional recruiting or active studies for the same condition.

See all trials for Acute lung injury

← Back to all trials